☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Merck and Eisai's Dual Regimen Receives the US FDA's Breakthrough Therapy Designation as 1L Treatment for Advanced Unresectable He...
July 23, 2019
Baxter's Myxredlin Ready-To-Use Insulin for IV Infusion Receives FDA's Approval for Diabetes Mellitus
July 23, 2019
Sanofi Signs an Exclusive Agreement with Roche for OTC Rights of Tamiflu (oseltamivir phosphate) in the US
July 23, 2019
ViiV Healthcare Reports Results of Fostemsavir in P-III BRIGHTE Study for HIV-1 infection
July 23, 2019
AstraZeneca Reports Inclusion of Overall Survival Data in Labelling of Imfinzi (durvalumab) in the US
July 23, 2019
Merck and Eisai's Keytruda (pembrolizumab) + Lenvima (lenvatinib) Receive FDA's Third Breakthrough Therapy Designation as 1L Thera...
July 23, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions